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Abstract
Skeletal muscle has a high regenerative capacity, injuries trigger a regenerative program
which restores tissue function to a level indistinguishable to the pre-injury state. How-
ever, in some cases where significant trauma occurs, such as injuries seen in military
populations, the regenerative process is overwhelmed and cannot restore full function.
Limited clinical interventions exist which can be used to promote regeneration and pre-
vent the formation of non-regenerative defects following severe skeletal muscle trauma.
Robust and reproducible techniques for modelling complex tissue responses are essen-
tial to promote the discovery of effective clinical interventions. Tissue engineering has
been highlighted as an alternative method, allowing the generation of three-dimensional
in vivo like tissues without laboratory animals. Reducing the requirement for animal
models promotes rapid screening of potential clinical interventions, as these models are
more easily manipulated, genetically and pharmacologically, and reduce the associated
cost and complexity, whilst increasing access to models for laboratories without animal
facilities. In this study, an in vitro chemical injury using barium chloride is validated using
the C2C12 myoblast cell line, and is shown to selectively remove multinucleated
myotubes, whilst retaining a regenerative mononuclear cell population. Monolayer cul-
tures showed limited regenerative capacity, with basement membrane supplementation
or extended regenerative time incapable of improving the regenerative response. Con-
versely tissue engineered skeletal muscles, supplemented with basement membrane pro-
teins, showed full functional regeneration, and a broader in vivo like inflammatory
response. This work outlines a freely available and open access methodology to produce
a cell line-based tissue engineered model of skeletal muscle regeneration.
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1 | INTRODUCTION
For the majority of individuals skeletal muscle injuries are regenera-
tive, restoring function to a level indistinguishable from that seen
before injury. The severity of muscle wounds seen in clinical settings
is highly varied, ranging from minor strains to significant muscle
traumas such as volumetric muscle loss. Typically, wounds caused by
military trauma or severe sports injury, do not retain full regenerative
capacity and complete recovery is not observed (Belmont, McCriskin,
Sieg, Burks, & Schoenfeld, 2012; Dharm-Datta & McLenaghan, 2013;
Wheatley et al., 2015). In addition, individuals with genetic conditions,
collectively termed myopathies, also experience a lack of regeneration
following injury (Dimachkie & Barohn, 2014; Flanigan, 2014; Nigro &
Piluso, 2015; Shieh, 2013). In such situations the capacity of muscle
to heal is impaired, resulting in non-regenerative healing and subse-
quent fibrosis (Mann et al., 2011; Mueller, Van Velthoven, Fukumoto,
Cheung, & Rando, 2016; Olson & Soriano, 2009), adipogenesis (Rose,
2002; Uezumi, Fukada, Yamamoto, Takeda, & Tsuchida, 2010; Uezumi
et al., 2011), and in extreme cases osteogenesis (Belmont et al., 2012;
Wheatley et al., 2015).
Mature adult skeletal muscle consists of aligned myofibres, encased
within a basement membrane and a predominantly type I collagen
extracellular matrix (ECM). These multinucleated cells contain the con-
tractile apparatus of skeletal muscle, with the force generated transmit-
ted through the ECM to the tendons (Cooke, 2004; Szent-Györgyi,
2004). Located between the membrane of these multinucleated cells
(sarcolemma) and the basement membrane resides a population of stem
cells, termed satellite cells, which are required for muscle hypertrophy
and regeneration (Hurme & Kalimo, 1992; Kuang, Kuroda, Le Grand, &
Rudnicki, 2007; Mauro, 1961; Moss & Leblond, 1971). Following injury,
satellite cells activated by the post injury environment proliferate rap-
idly producing large numbers of progeny (Doumit, Cook, & Merkel,
1993; Haugk, Roeder, Garber, & Schelling, 1995; Hurme & Kalimo,
1992), which express early markers of myogenic commitment (Kuang
et al., 2007). It is these progeny which commit to the myogenic lineage
fusing to regenerate the damaged myofibres and return full functionality
(Cornelison et al., 2004; Seale et al., 2000). A number of studies have
shown the importance of inflammatory mediators on muscle progenitor
proliferation and differentiation, and so the role of inflammation in regen-
eration is seen as an essential coordinating event following injury (Arnold
et al., 2007; Lu et al., 2010; Segawa et al., 2008; Summan et al., 2006).
Currently, limited pharmacological interventions are available, in
clinical practice, to increase regenerative repair within injured and/or
diseased populations. As such, individuals that fall into these groups are
left with skeletal muscle which never recovers full function, and in
many cases can cause long term pain and disability. The processes
governing skeletal muscle regeneration are highly complex, relying
upon the coordinated effects of multiple cell types in vivo. To date,
studies of muscle regeneration have relied upon the use of animal
models. However, attempts to reduce the reliance upon animals
models, as per the 3Rs directive (EU, 2010; Russell, Burch, & Hume,
1959), in addition to difficulties translating animal data to human
physiology (Boldrin, Muntoni, & Morgan, 2010; Gerry & Leake, 2014;
Shanks, Greek, & Greek, 2009), demonstrates a requirement for new
approaches. Recreating complex biological processes, such as skeletal
muscle regeneration in in vitro tissue culture systems, requires sophisti-
cated models of tissues which go beyond simple monolayer cultures.
Examination of cellular responses typically relies upon monolayer
cell culture methods; however, these monolayer culture methods lack
the advanced tissue hierarchy seen in vivo. The lack of spatial organisa-
tion in monolayer models may limit the capacity of cellular models to
undergo complex physiological events, such as muscle regeneration.
Tissue engineering has been highlighted as an alternative method, all-
owing the generation of three-dimensional in vivo like tissues without
the need for laboratory animals. Reducing the requirement for animal
models promotes rapid screening of potential clinical interventions, as
these models are easily manipulated genetically and pharmacologically
and therefore are associated with reduced cost and complexity.
A number of tissue engineered models of skeletal muscle have been
published which are capable of producing a 3D construct that contains
aligned myofibres (Agrawal, Aung, & Varghese, 2017; Gilbert-honick
et al., 2018; Huang, Dennis, Larkin, & Baar, 2005; Juhas, Engelmayr,
Fontanella, Palmer, & Bursac, 2014; Langelaan et al., 2011; Madden,
Juhas, Kraus, Truskey, & Bursac, 2015; Martin et al., 2013; Rao, Qian,
Khodabukus, Ribar, & Bursac, 2018; Sakar et al., 2012; Sharples et al.,
2012; Vandenburgh et al., 2009; Vandenburgh, 2010), and in some
cases capable of producing force when electrically stimulated (Capel
et al., 2019; Juhas et al., 2014; Madden et al., 2015; Martin et al., 2017;
Rao et al., 2018). These models have been used for a range of applica-
tions including preclinical drug screening and investigations of basic
biology. To date only a single model has shown any regenerative capac-
ity. This study employed a fibrin/Matrigel® hydrogel system containing
primary skeletal muscle myoblasts from rats (Juhas et al., 2014, 2018).
The culture system employed is based upon a bespoke 3D culture
mould and uses primary rat myogenic precursor cells (requiring the sac-
rifice of small laboratory animals), negating some of the advantages
associated with using engineered tissues as models. Therefore, a sys-
tem that employs a freely available and open source 3D printed mould,
to allow other investigators to accurately and rapidly reproduce the sys-
tem, and does not use any primary animal tissue, represents a signifi-
cant advance to the tissue engineering field.
Here, we present a comparative analysis of injury and regeneration
in both monolayer and tissue engineered 3D culture systems using the
murine skeletal myoblast cell line C2C12. Morphological analysis, gene
expression and functional output are used to assess the differences and
similarities between monolayer and 3D model systems and identify a
system which most closely mimics in vivo skeletal muscle regeneration.
2 | METHODS
2.1 | Culture of C2C12 skeletal muscle myoblasts
C2C12 skeletal muscle myoblasts (below passage 10) were expanded
using growth medium (GM); composed of 79% Dulbecco's Modified
Eagle Medium (DMEM, Fisher Scientific, UK), 20% foetal bovine serum
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(FBS, Pan Biotech, UK) and 1% Penicillin/Streptomycin (P/S, Fisher). Cells
were cultured in T80 flasks (NuncTM, Fisher) and incubated in a 5% CO2
humidified atmosphere at 37 C until 80% confluence was attained. GM
was changed every 24 hr during the expansion of cells.
2.2 | Monolayer (2D) culture
Cells were plated into six well plates containing 0.2% gelatin coated
glass cover slips at a density of 1 × 104 cells/cm2. To examine the
effect of surface matrix, experimental plates and coverslips were
coated with a 1.5 mg/mL Matrigel® solution as per manufacturer's
instructions (Corning, UK). Myoblasts were cultured to confluence in
GM before being cultured in low serum differentiation medium (DM);
composed of 97% DMEM, 2% Horse Serum (HS, Sigma Aldrich, UK)
and 1% P/S. The total culture period was standardised at 2 days GM,
followed by a further 3 days DM.
2.3 | 3D tissue engineered constructs
Collagen constructs were generated using C2C12 myoblasts, as previously
published (Capel et al., 2019). Type I collagen only hydrogels were formed
by the addition of 85% vol/vol type I rat tail collagen (First Link, UK; dis-
solved in 0.1 M acetic acid, protein at 2.035 mg/mL), with 10% vol/vol of
10X minimal essential medium (MEM, Gibco, UK). This solution was
neutralised by the addition of 5 M and then 1 M sodium hydroxide
(NaOH) dropwise, until a colour change to cirrus pink was observed. Col-
lagen/Matrigel® constructs were generated by the addition of 65% vol/vol
type I rat tail collagen, with 10% vol/vol of 10X minimal essential medium.
This solution was neutralised as above. This was followed by the addition
of 20% vol/vol Matrigel® (Corning®, Germany). Myoblasts were added to
the neutralised collagen or collagen/Matrigel® solution at a density of
4 × 106 cells/mL in a 5% vol/vol GM solution, before being transferred to
the pre-sterilised biocompatible polylactic acid (PLA) 3D printed inserts
(Rimington, Capel, Christie, & Lewis, 2017) to set for 10–15 min in an
incubator. Collagen only gels were set in 500 μL inserts (Rimington et al.,
2018a), whilst Matrigel®/Collagen gels were set in 50 μL inserts
(Rimington et al., 2018b, 2018c). All moulds used in this manuscript are
freely available to download at the following URL: https://figshare.com/
projects/3D_Printed_Tissue_Engineering_Scaffolds/36494. GM was
added for 4 days and changed daily, before being changed to DM,
refreshed every 2 days, for a further 10 days in culture. Figure S5 contains
a cross sectional image and macroscopic image of deformed hydrogels to
illustrate the morphology and appearance of mature control constructs.
2.4 | Barium chloride injury and regeneration
Barium chloride (BaCl2) was chosen as an injurious stimulus due to
previous in vivo publications and its high water solubility, allowing
easy and reproducible in vitro application (Hardy et al., 2016; Mueller
et al., 2016). Once cultures had reached maturity, as defined above,
they were exposed to chemical injury by BaCl2. Prior to inducing
injury, fresh DM was added to all conditions. Precisely 50 μl/mL of
12% wt/wt BaCl2 solution was then added to the medium for injury
culture conditions, followed by a 6 hr incubation to cause injury. Fol-
lowing injury, cultures were washed once with phosphate buffered
saline (PBS) to remove residual BaCl2 containing media. Control
(no injury) and 0 hr (0 hrs) time points were collected at the end of
injury incubation. Injury was followed by a regenerative period, and in
all experiments this regenerative period mimicked exactly the protocol
used to generate mature cultures, allowing comparison of regenerated
cultures to controls. End GM time points were collected when reg-
enerating cultures were changed from GM to DM. End DM time
points were collected at the end of the experimental protocol.
2.5 | Fluorescence staining
Cells and 3D constructs were fixed using a 3.75% formaldehyde solu-
tion (Sigma). The actin cytoskeleton of cells was identified using rho-
damine phalloidin (1:500, Fisher) and nuclei were stained using
40 ,6-diamidino-2-phenylindole (DAPI, 1:1,000, Fisher) in tris-buffered
saline (TBS) for 2 hr. Coverslips and 3D constructs were then washed
(3 × 15 min, TBS). Coverslips were mounted directly onto microscope
slides using Fluoromount™ mounting medium (Sigma). Constructs were
transferred to polysine adhesion microscope slides (Fisher) and mounted
under glass coverslips, again using Fluoromount™mounting medium.
2.6 | Image collection and analysis
Images were captured using a Leica DM2500 (monolayer) or a Zeiss LSM
880 confocal (3D) microscope. Morphological measures; fusion index
(number of nuclei in myotubes represented as a percentage of the total
number of nuclei in the image frame), myotube density per 100 μm (num-
ber of myotubes measured intersecting a line drawn perpendicular to the
long axes of the construct, averaged from five points per image), percent-
age coverage (myotube width multiplied by myotubes per 100 μm) and
average myotube width were all conducted manually. Total nuclei were cal-
culated using an in-house macro implemented in ImageJ (Schindelin et al.,
2012). Analysis was conducted from nine monolayer images taken across
three coverslips per biological repeat, or from a 21-image tile scan of a 3D
construct for every condition, derived from n ≥ 3 biological repeats.
2.7 | Assessment of muscle function by electrical
stimulation
Electric field stimulation was used to assess the functional capacity
(force generation) of tissue engineered constructs. Constructs were
washed twice in PBS, and one end of the construct removed from the
supporting mould pin. The loose end of the construct was then
attached to the force transducer (403A Aurora force transducer,
Aurora Scientific, Canada) using the eyelet present in the construct.
The construct was positioned to ensure its length was equal to that
before removal from the pin and covered (3 mL) with Krebs-Ringer-
HEPES buffer solution (KRH; 10 mM HEPES, 138 mM NaCl, 4.7 mM
KCl, 1.25 mM CaCl2, 1.25 mM MgSO4, 5 mM Glucose, 0.05% Bovine
Serum Albumin in dH2O, Sigma). Aluminium wire electrodes, sepa-
rated by 10 mm, were positioned either side of the construct to allow
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for electric field stimulation. Impulses were generated using LabVIEW
software (National Instruments, Berkshire, UK) connected to a
custom-built amplifier. Maximal twitch force was determined using a
single 3.6 V/mm, 1.2 ms impulse and maximal tetanic force was mea-
sured using a 1 s pulse train at 100 Hz at 3.6 V/mm, generated using
LabVIEW 2012 software (National Instruments). Where possible,
twitch and tetanus data were derived from three contractions per
construct, and a minimum of two constructs per time point per biolog-
ical repeat. Data was acquired using a Powerlab system (ver. 8/35)
and associated software (Labchart 8, AD Instruments, UK).
2.8 | RNA extraction and RT-PCR
RNA was extracted using TRIReagent® chloroform extraction,
according to manufacturer's instructions (Sigma). RNA concentration
and purity were obtained by UV spectroscopy (Nanodrop 2000, Fisher).
For snap frozen 3D constructs, TRIReagent® extraction was augmented
by mechanical disruption of hydrogels via addition of metal beads in
round bottomed Eppendorf's (Starlab, UK) in a TissueLyser II (Qiagen,
UK) for 5 min at 20 Hz. Following disruption, beads were removed, and
RNA was isolated as for monolayer samples.
All primers (Table 1) were validated for 5 ng of RNA per 10 μL real
time-polymerase chain reaction (RT-PCR) reaction. RT-PCR amplifica-
tions were carried out using Power SYBR Green RNA-to-CT 1 step kit
(Qiagen, UK) on a 384 well ViiA Real-Time PCR System (Applied Bio-
systems, Life Technologies), and analysed using ViiA 7RUO Software.
RT-PCR procedure was: 50 C, 10 min (for cDNA synthesis), 95 C,
5 min (reverse transcriptase inactivation), followed by 40 cycles of
95 C, 10 s (denaturation), 60 C, 30 s (annealing/extension). Melt anal-
ysis was then carried out using standard ViiA protocol. Relative gene
expressions were calculated using the comparative CT (ΔΔCT) method
giving normalised expression ratios (Schmittgen & Livak, 2008). RPIIβ
was the designated housekeeping gene in all RT-PCR assays and no
sample controls for each primer set were included on every plate.
2.9 | Statistical analysis
Statistical significance of data was determined using IBM© SPSS© Sta-
tistics version 23. Mauchly's test of sphericity and Shapiro–Wilk tests
were used to confirm homogeneity of variance and normal distribution
of data, respectively. Where parametric assumptions were met, an
ANOVA test was used to identify significant interactions. Where signif-
icant interactions were observed, Bonferroni post-hoc analyses were
used to analyse differences between specific time-points. Non-
parametric Kruskal–Wallis analysis was undertaken where data violated
parametric assumptions. Mann–Whitney (U) tests were then used, with
a bonferonni correction, to identify the differences between groups. All
data is reported as mean ± SD. Significance was assumed at p ≤ .05.
3 | RESULTS
3.1 | Monolayer muscle cultures exhibit only a partial
regenerative response following injury
To cause a wounding insult in 2D, a mechanism of injury is required
that specifically removes myotubes, without causing excessive
TABLE 1 Forward and reverse primer
sequences for all primers used for RT-
PCR expression analysis
Primer Sequence (50 to 30) Product length
NCBI reference
sequence
RPIIβ Fw-GGTCAGAAGGGAACTTGTGGTAT 197 NM_153798.2
Rv-GCATCATTAAATGGAGTAGCGTC
Myod Fw-CATTCCAACCCACAGAAC 125 NM_010866.2
Rv-GGCGATAGAAGCTCCATA
Myog Fw-CCAACTGAGATTGTCTGTC 173 NM_031189.2
Rv-GGTGTTAGCCTTATGTGAAT
Myh3 Fw-CATATCAGAGTGAGGAGGAC 86 NM_001099635.1
Rv-CTTGTAGGACTTGACTTTCAC
Tnf Fw-TCAACAACTACTCAGAAACAC 130 NM_013693.3
Rv-AGAACTCAGGAATGGACAT
Il6 Fw-AAGAAATGATGGATGCTACC 164 NM_001314054.1
Rv-GAGTTTCTGTATCTCTCTGAAG
Mcp1 Fw-CAAGATGATCCCAATGAGTAG 87 NM_011333.3
Rv-TTGGTGACAAAAACTACAGC
Pparg Fw-AAAGACAACGGACAAATCAC 195 XM_017321456.1
Rv-GGGATATTTTTGGCATACTCTG
Runx2 Fw-ACAAGGACAGAGTCAGATTAC 197 XM_006523545.2
Rv-CAGTGTCATCATCTGAAATACG
Note: Product length and NCBI gene reference determined using NCBI primer blast.
Abbreviation: RT-PCR, real time-polymerase chain reaction.
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damage to the mononuclear cell population. The chemical BaCl2 was
selected, demonstrating a dose dependent ability to specifically
remove myotubes (Figure S1). Furthermore, BaC12 has been docu-
mented to induce injury in animal models of skeletal muscle regenera-
tion (Hardy et al., 2016).
BaCl2 insult in monolayer cultures caused total removal of
myotubes, demonstrated by the significant ablation of fused nuclei
(p < .001), however no reduction in total nuclei number indicates the
retention of mononuclear cells following injury (Figure 1a–c). Follow-
ing a further 2 days culture in GM, nuclei number was significantly
F IGURE 1 Treatment of differentiated C2C12 cultures with BaCl2 specifically removes myotubes from culture and initiates a regenerative
response. (a) ×20 widefield micrographs of recovery time points in C2C12s. Stained for actin (phalloidin, red) and nuclei (DAPI, blue), scale bars
represent 50 μm. (b) Fusion index, (c) total nuclei, (d,e) measures of myotube maturity. Values for 0 hr and 2 days post injury have been omitted
as too few myotubes were present in these conditions to accurately measure these variables (b–e) Graphs express mean ± SD, asterisks above
bars denotes significance from control, ***denotes significance p < .001, (f–i) RT-PCR analysis of cellular developmental and inflammatory
markers. All graphs display mean ± SD, *denotes significance p < .05, **denotes significance p < .01, ***denotes significance p < .001.
(j) Experimental timeline for generation of differentiated C2C12 culture, injury and subsequent recovery. RT-PCR, real time-polymerase chain
reaction [Color figure can be viewed at wileyonlinelibrary.com]
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increased (p < .001), without a corresponding increase in fusion index,
outlining a proliferative response to BaCl2 insult without myoblast
fusion. Following 3 days in DM fusion index recovered from 0 to 48%
of the value at control (p < .001), but remained significantly reduced
compared to control (p < .001). Nuclei per image frame remained sig-
nificantly elevated compared to control after 5 days regeneration
(p < .001), but returned to baseline following a further 3 days regener-
ation (Figure S2). No difference was observed in indicators of matu-
rity; myotube width or nuclei per myotube, from control (Figure 1d,
e, p > .05).
Increases in nuclei number without commitment to fusion, sug-
gests a blockade in myogenesis following BaCl2 insult. As such, an
examination of genes involved in myogenesis and skeletal muscle
maturity were undertaken. Embryonic myosin heavy chain, Myh3,
expression correlated with fusion index (Figure 1f), although no signif-
icant reduction was identified between control and 5 days (p = .09).
The transcriptional regulators of myogenesis, Myod and Myog,
expression levels were supressed although not significantly 2 days
post injury (Figure 1g, p > .05). Both Myod and Myog showed signifi-
cant increases (p < .001) during DM phase of recovery, consistent
with an activation of myogenesis and a level of regeneration. Non-
myogenic commitment to osteogenic lineage was measured via the
expression of Runx2, although no significant increase above control
was observed (p > .05). An upward trend in the expression of the
adipogenic marker Pparg across recovery was evident, with significant
increases in this gene observed after 5 days regeneration compared
to immediately post injury (Figure 1h, p = .041). The role of inflamma-
tory signalling in injury and regeneration is well established. As such,
inflammatory genes encoding for interleukin-6 (Il6) and macrophage
chemoattractant protein-1 (Mcp1/Ccl2) were used to analyse levels
of inflammation induced by BaC12 administration. Il6 expression
increased 36-fold (p = .0013) when compared to immediately post
injury. This was, completely resolved following 2 days recovery in GM
(p < .05). Mcp1 displayed no significant upregulation at any time-point
throughout the recovery process (Figure 1i).
The recovery of myogenic genes Myod and Myog (Figure 1g)
suggested that although myogenic precursors were present in cultures
after 5 days post injury, myogenic progression was not sufficiently
advanced to enable the fusion required at this time-point to fully
regenerate ablated myotubes. To examine whether extended regener-
ative periods were sufficient to initiate full recovery, time in DM was
extended by a further 3 days, taking the total regeneration time to
8 days. Despite this no increase in fusion index was observed
between 5 and 8 days regeneration (Figure S2).
3.2 | Type I collagen based tissue engineered
muscles lack regenerative capacity following injury
A widely published system for the culture of tissue engineered skele-
tal muscle is the use of type I collagen hydrogels (Smith, Passey,
Greensmith, Mudera, & Lewis, 2012; Vandenburgh et al., 2009), gen-
erating aligned myotubes via longitudinal tension. This well-
established model was utilised to examine if the incorporation of cells
into a tissue engineered environment was sufficient to support full
regeneration.
Following insult, significant reductions in myotube density were
observed (p < .001, Figure 2a,b), accompanied by decreased total
nuclei (Figure 2c). During the regenerative period, recovery of
myotube density was completely inhibited (Figure 2a), with reductions
in nuclei number also evident across time (Figure 2c). This data sug-
gests that hydrogels composed solely of type I collagen do not sup-
port regeneration following injury, and so are not a viable ex vivo
model of skeletal muscle regeneration.
3.3 | Inclusion of basement membrane proteins in
the form of Matrigel® is sufficient to support
regeneration in 3D
The potential lack of a stem cell like niche between the sarcolemma
and basement membrane in hydrogels consisting of type I collagen
only, could explain the inability to regenerate. To confirm the require-
ment for a basement membrane, hydrogels containing the basement
membrane supplement Matrigel® were injured and allowed to regen-
erate. Hydrogels composed of collagen/Matrigel® were cultured in
50 μl inserts compared to 500 μl for collagen only hydrogels, to
increase experimental throughput. The comparison of the mould sizes
has been made previously and shown to be consistent (Capel
et al., 2019).
Immediately following injury in collagen/Matrigel® hydrogels,
myotube density and coverage were significantly reduced (p < .001,
Figure 3a,b), demonstrating that 6 hr BaCl2 exposure remains suffi-
cient to induce injury. Following 4 days (End GM) of regeneration,
myotube density recovered to control levels and remained stable over
the remaining 10 days (End DM, Figure 3b). Myotube coverage
remained significantly reduced at both End GM and End DM time
points (p < .001, p = .015, Figure 3b). This is due to significant reduc-
tions in myotube width from 23.6 μm (control) to 19.1 μm at 14 days
following injury (Figure 3d). No variation over time was seen in total
nuclei per image frame, and so no proliferative response was observed
(Figure 3c). Morphological decreases in myotube width did not trans-
late to reduced functional output (Figure 3e), with force reduced fol-
lowing injury, but recovering completely at End GM time point.
Although not statistically significant, force generation was enhanced
at End DM. Twitch force outputs were on average 2.5-fold higher and
tetanus 2.8-fold higher than control. Figure 3f shows representative
force traces at two frequencies for control gels, no difference in force
trace shape was observed during recovery.
To examine the molecular mechanisms of regeneration, gene
expression analysis was carried out on myogenic (Figure 4a), myosin
heavy chains (Figure 4b), inflammatory genes (Figure 4c) and non-
myogenic developmental genes (Figure 4d). Myogenic markers Myod
and Myog were expressed at significantly lower levels throughout
regeneration (p = .013, p = .001), with the only myogenic marker
expressed at an increased level being the embryonic myosin heavy
chain, Myh3. Myh3 was significantly increased (p = .018) by 52% com-
pared to control immediately following injury, however throughout
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regeneration transcription of this gene reduced across time to 45% of
control at End DM 14 days later. Expression of myosin heavy chains
associated with increased maturity, Myh8 (perinatal) and Myh1
(mature), initially were reduced (18% and 38%, respectively) followed
by an increase through recovery from 4 days post injury onwards. At
14 days post injury (End DM), both Myh8 and Myh1 expression were
elevated compared to control although not significantly.
Il6 was elevated 34-fold in 2D experiments (Figure 1i), however
was only up-regulated 4.2-fold in 3D (p = .024). Il6 expression ret-
urned to baseline 4 days (End GM) following injury and remained simi-
lar to control for the remainder of regeneration (Figure 4b). Mcp1 was
elevated immediately following injury (fourfold, p = .011), and was
expressed twofold higher than control at End GM time point although
not significant. At the end of regeneration, Mcp1 expression returned
to baseline levels (Figure 4b). To examine if injury was promoting non-
myogenic commitment of mononuclear cells, the markers Pparg
(adipogenic) and Runx2 (osteogenic) were also quantified, although no
significant variation from control expression was observed (Figure 4c).
To ensure that the addition of basement membrane components
and growth factors contained within Matrigel® was not the sole cause
of regeneration seen in tissue engineered constructs, further 2D
experiments using Matrigel® coated coverslips were carried out. BaCl2
injury caused a significant reduction in fusion index (p < .001), that
despite recovering significantly (p = .016), remained significantly
(p < .001) below control at experimental termination (Figure S3). A
proliferative phase was evident at End GM time-point (Figure S3), in
addition to consistent myotube widths pre and post injury. Significant
reductions in nuclei per myotube were observed (p = .031); however,
this was the only variation from the trends observed with gelatin as a
substrate. Increased fusion index at control and following injury could
potentially affect the regenerative process; however, correlation anal-
ysis shows no relationship between fusion, before or after injury, and
the level of regeneration (Figure S4). This data confirmed the require-
ment for a 3D environment for full regeneration.
4 | DISCUSSION
In this study, we present a model of skeletal muscle regeneration
which requires no laboratory animal sacrifice or donor tissue and is
designed to be straightforward to replicate between laboratories. In
addition, we have made a direct comparison of monolayer to 3D
F IGURE 2 Type I collagen hydrogels lack regenerative capacity following injury. (a) representative confocal microscope tile scans at ×40
magnification consisting of 21 individual images. Stained with phalloidin (red) and DAPI (blue) to identify actin and nuclei, respectively. Scale bars
denote 250 μm. (b) Myotube density expressed as myotubes per 100 μm. Mean ± SD. (c) Total nuclei per image frame. Mean ± SD, *p < .05.
(d) Experimental time course of the 28 day 3D recovery experiment [Color figure can be viewed at wileyonlinelibrary.com]
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F IGURE 3 Inclusion of Matrigel® allows 3D culture models to support regeneration following insult from BaCl2. (a) Representative tile
scans at ×40 magnification, phalloidin staining (red) and DAPI (blue) identify actin and nuclei, respectively. Scale bars represent 100 μm.
(b) Myotube density expressed as myotubes per 100 μm (solid bars) and percentage of gel occupied by myotubes (hashed bars). Mean ± SD,
significance from control denoted by asterisks above bars, **p < .01, ***p < .001. (c) Nuclei per image frame. Mean ± SD. (d) Myotube width (μm).
Mean ± SD, significance from control ***p < .001. (e) Force output data, twitch (1 Hz, solid bars) and fused tetanus (100 Hz, hashed bars) peak
force expressed as mean ± SD, significance from control, **p < .01. (f) Representative force traces for C2C12 constructs stimulated at different
frequencies to achieve; single twitch (1 Hz) and fused tetanus (100 Hz) [Color figure can be viewed at wileyonlinelibrary.com]
378 FLEMING ET AL.
culture to ensure that the increased complexity of 3D culture
improves the biological relevance of results obtained.
In monolayer, C2C12 cultures showed limited regeneration fol-
lowing injury and so lacked a fully regenerative response. As the
C2C12 cell line is a committed cell line, analysis of stem cell activation
which is possible in primary derived myogenic precursors is not possi-
ble, however this cell line does allow the committed myogenic compo-
nent of regeneration to be isolated. Therefore, the RNA levels of
Myod and Myog have been examined to indicate the commitment of
cells to myogenesis. An increase in Myod and Myog was observed
only in the DM phase of recovery in monolayer cultures, suggesting a
requirement for a change in serum concentration to trigger the myo-
genic program activating these canonical transcription factors. This
recovery of Myod and Myog RNA levels but not of myotubes,
suggesting a blockade of myogenesis at a late developmental stage.
This blockade is most likely preventing the fusion of myoblasts into
myotubes (Bentzinger, Wang, & Rudnicki, 2012). In addition to the
potential myogenic blockade an increase in the non-myogenic
adipogenic transcription factor Pparg (Memon et al., 2000; Siersbæk,
Nielsen, & Mandrup, 2010) suggest a proportion of cells in the culture
commit to non-myogenic developmental lineages, again blocking
myogenesis. In contrast to monolayer cultures Myod and Myog were
seen to fall continuously through recovery in engineered tissues, with-
out the upregulation seen during the DM phase of regeneration in
monolayer. As regeneration was morphologically complete by 4 days
post injury, the upregulation of Myod and Myog required for
myogenesis followed by subsequent down regulation (Bentzinger
et al., 2012) may have occurred in the GM phase of recovery and
therefore expression of these genes was resolved by 4 days post
injury. Rapid induction of Myh3 (embryonic/regenerative) is seen
immediately post injury, and is a response to injury consistent
with in vivo models, which see preferential expression of
regenerative/embryonic isoforms of myosin heavy chains during
regeneration (Gorza, Sartore, Triban, & Schiaffino, 1983; Hindi &
Kumar, 2016; Schiaffino, Rossi, Smerdu, Leinwand, & Reggiani, 2015).
This response to switch to embryonic myosin may protect remaining
myotubes from further injury and perhaps increase the ability of these
myotubes to regenerate and support myogenesis. Throughout regen-
eration Myh3 expression falls and Myh8 (perinatal) and Myh1
(mature) isoforms increase in expression, showing a return to a mature
phenotype and recovery from injury. At 14 days post injury increased
Myh8 and Myh1 expression compared to controls suggests a more
mature phenotype, and potentially explains the non-significant
increase in force production at End DM time point. Force generation
in skeletal muscle is dependent upon a myriad of contributing factors
and as such this is likely to be one of numerous contributing variables.
Myh3 expression in monolayer matches the morphological trends,
with no increased Myh3 expression immediately post injury. This sug-
gest no isoform hand over as seen in engineered tissues, and instead
an early blockade of myogenesis shown by the late elevation of Myod
and Myog. This rapid regeneration of engineered tissues in GM high-
lights the regenerative capacity of the 3D environment, in the absence
of external serum concentration changes. This inherent ability of the
engineered tissues to produce the required cues to drive myogenesis
F IGURE 4 RT-PCR analysis of gene expression during recovery of 3D tissue engineered muscle. (a–d) All graphs display means ± SD,
significance from control denoted by asterisk; *p < .05, **p < .01. RT-PCR, polymerase chain reaction
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without external signals is desirable, as muscle derived factors are
known to drive regeneration in vivo and appear to be doing so in this
engineered tissue.
Inflammatory factors present in regeneration have been shown to
promote proliferation of myogenic cells (Hoene, Runge, Haring,
Schleicher, & Weigert, 2013; Yahiaoui, Gvozdic, Danialou, Mack, &
Petrof, 2008), and indeed a proliferative response post injury is
observed in monolayer. When Il6 and Mcp1 expression were exam-
ined, only Il6 was upregulated immediately post injury and rapidly
resolved. No induction of Mcp1 suggests an incomplete inflammatory
response which may contribute to the reduced regenerative capacity
of monolayer cultures. In vivo data suggests the major role of MCP-1
is as a monocyte chemoattractant with its removal impairing regener-
ation (Shireman et al., 2006), and therefore the lack of Mcp1 expres-
sion reduces the biological relevance of the monolayer model. This
limits its suitability for studying interactions with immune cells in
future work narrowing the potential applications of monolayer stud-
ies. The lack of an improved regenerative response in the presence of
basement membrane proteins, or increased culture time, suggest that
monolayer cultures have an inherently limited regenerative capacity
following a significant injurious insult.
Collagen I based tissue engineered skeletal muscles showed no
regenerative capacity; however, the addition of Matrigel® was suffi-
cient to allow regeneration following injury, showing the importance
of basement membrane proteins in regenerative processes. Further-
more, the 3D organisation of these proteins must be a requirement
for regeneration as basement membrane supplementation in mono-
layer was shown to be insufficient to support full regeneration. The
presence of a niche with 3D organisation is key for defining stem cell
proliferation, lineage commitment and self-renewal in in vivo muscle
and the 3D environment supplied by tissue engineered muscles is able
to reproduce this in a way that is impossible in monolayer culture. The
presence of this regenerative niche within collagen/Matrigel®
engineered muscles allows potential future work to examine how dif-
ferent injury mechanisms, which may disrupt this niche, affect
regeneration.
The full morphological regeneration of myotube number and full
functional regeneration matches the response to BaCl2 insult in in vivo
experiments (Hardy et al., 2016). The ability to measure functional
output, something not possible in monolayer cultures, is a major
advantage of 3D systems allowing direct and rapid assessment of tis-
sue function which is the primary clinical measure of recovery from
injury. The inflammatory response of 3D cultures was also shown to
be more biomimetic than monolayer. Both Il6 and Mcp1 showed
increased expression, compared to Il6 alone in monolayer, this
increased number of inflammatory cytokines adds complexity to the
regenerative environment post injury. As immune cells play an impor-
tant role in directing and regulating skeletal muscle regeneration an
inflammatory response as close to in vivo as possible will be required
to understand the interaction between muscle and immune cells. As
such we see the tissue engineered model presented as superior to the
monolayer equivalent as it not only provides a fully regenerative
response and functional output but expresses a fuller inflammatory
response to injury important for the recruitment and activation of
immune cells which support regeneration in vivo.
This study, which compares directly the use of the same injury
mode in both monolayer and 3D cultures, demonstrates the useful-
ness of tissue engineered models for disease, and highlights where
these models can be used to produce results superior to monolayer
culture. We also recognise that monolayer culture is still widely used
for preclinical interventions and have shown that a monolayer model
of skeletal muscle regeneration is perhaps of use for some applica-
tions which require only limited biological relevance. Previous work
demonstrating regeneration in tissue engineered muscles relies upon
isolation of myogenic precursors from rat tissue (Juhas et al., 2014,
2018), whereas this study presents a cell line based model contained
within a 3D printed mould making it suitable from high throughput
work often required in therapeutic development. We show that
regeneration of tissue engineered skeletal muscles containing base-
ment membrane proteins provides a system which is representative
of the in vivo response to chemical injury, providing a platform for the
investigation of the myogenic events which underpin regeneration.
This model can be used as a tool for researchers to obtain in vivo like
results without requiring laboratory animals, improving the relevance
of preclinical screening and potentially reducing failure rates of novel
clinical interventions.
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